DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Slavik L, Jacova J, Friedecky D. et al.
Evaluation of the DOAC-stop procedure by LC-MS/MS assays for determining the residual activity of dabigatran, rivaroxaban, and apixaban.
Clin Appl Thromb Hemost 2019;
25: 1076029619872556
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.